HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.

[1]  B. Bonné-Tamir,et al.  Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3. , 1998, American journal of human genetics.

[2]  P. Gasparini,et al.  Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. , 1997, American journal of human genetics.

[3]  J. Marth,et al.  Alpha-Mannosidase-II Deficiency Results in Dyserythropoiesis and Unveils an Alternate Pathway in Oligosaccharide Biosynthesis , 1997, Cell.

[4]  R. Erickson.  Mouse models of human genetic disease: Which mouse is more like a man? , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[5]  P. Marks,et al.  Congenital dyserythropoietic anemias , 1996, American journal of hematology.

[6]  M. Mattei,et al.  Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Laine,et al.  Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes. , 1994, Glycobiology.

[8]  D. Melton,et al.  Gene targeting in the mouse. , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  P. de Cock,et al.  Carbohydrate-deficient glycoprotein syndrome type II , 1993, Journal of Inherited Metabolic Disease.

[10]  A. Dell,et al.  Incompletely processed N‐glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS) , 1992, British journal of haematology.

[11]  A. Dell,et al.  Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Fukuda.  HEMPAS disease: genetic defect of glycosylation. , 1990, Glycobiology.

[13]  A. Dell,et al.  Isolation and characterization of poly-N-acetyllactosaminylceramides accumulated in the erythrocytes of congenital dyserythropoietic anemia type II patients. , 1986, Chemistry and physics of lipids.

[14]  M. Anderson,et al.  Parvovirus infection associated with aplastic crisis in a patient with HEMPAS. , 1986, Journal of clinical pathology.

[15]  C. Lomas,et al.  Transient anti‐D in an Rh‐positive patient with congenital dyserythropoietic anemia type II , 1984, Transfusion.

[16]  U. Testa,et al.  Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS) , 1984, British journal of haematology.

[17]  M. Tanner,et al.  Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia Type II (CDA II) , 1983, British journal of haematology.

[18]  P. Scartezzini,et al.  Decreased glycosylation of band 3 and band 4‐5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II , 1982, British journal of haematology.

[19]  T. Gabuzda,et al.  Normal serum ferritin levels in a patient with HEMPAS syndrome and iron overload. , 1982, American journal of clinical pathology.

[20]  J. Banga,et al.  Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMPAS) , 1982 .

[21]  R. Lowenthal,et al.  Erythrocyte membrane proteins in an unusual case of congenital dyserythropoietic anaemia type II (CDA II) , 1982, British journal of haematology.

[22]  H. Heimpel,et al.  Congenital Dyserythropoietic Anaemia, Types I and II: Aberrant Pattern of Erythrocyte Membrane Proteins in CDA II, as Revealed by Two‐dimensional Polyacrylamide Gel Electrophoresis , 1977, British journal of haematology.

[23]  J. Gockerman,et al.  Accumulation of glycolipids containing N-acetylglucosamine in erythrocyte stroma of patients with congenital dyserythropoietic anemia type II (HEMPAS). , 1975, Biochemical and biophysical research communications.

[24]  R. Graham,et al.  Erythrocyte lipids and vitamin E in type II congenital dyserythropoietic anemia. , 1974, The Journal of pediatrics.

[25]  S. Lewis,et al.  Hereditary Erythroblastic Multinuclearity Associated with a Positive Acidified‐Serum Test: a Type of Congenital Dyserythropoietic Anaemia , 1969, British journal of haematology.

[26]  G. Holmgren,et al.  Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. , 1995, Human molecular genetics.

[27]  S. Perrotta,et al.  Congenital dyserythropoietic anemia type II associated with G6PD Seattle in a Sicilian child. , 1995, Acta haematologica.

[28]  M. Fukuda.  Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis. , 1993, Bailliere's clinical haematology.

[29]  P. Jacobs,et al.  Congenital dyserythropoietic anaemia (type II) presenting with haemosiderosis. , 1987, Acta haematologica.

[30]  Y. Levo,et al.  Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. , 1985, Acta haematologica.

[31]  L. Luzzatto,et al.  Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza). , 1984, Acta haematologica.